Thymofaxine can be injected under the supervision of a doctor for minor triple positive. Thymofaxine is an immunomodulatory drug, mainly used for subcutaneous injection. It is suitable for the treatment of chronic hepatitis B. It can also be used as a vaccine immune response booster for immuno-compromised patients, but it is more expensive, so you can choose whether to use it or not according to your own financial conditions and after consulting your physician’s advice. This drug produces viral remission (HBV-DNA is not measurable) and restitution of aminotransferase levels in the treatment of patients with chronic hepatitis B. Clinical trials have suggested that when this drug is used in combination with interferon it increases the response rate compared to this drug alone or interferon alone. Minor triple positive refers to the immunological indicators of hepatitis B virus in patients with chronic hepatitis B or hepatitis B virus carriers, i.e., hepatitis B surface antigen, hepatitis B e antibody and hepatitis B core antibody are positive. Thymofaxine can be injected as prescribed by the doctor for patients with minor triple positive. Thymofaxine is well tolerated and usually does not cause significant discomfort. Temporary fluctuations in alanine aminotransferase levels may occur during treatment with thymofacine in patients with minor triple positive hepatitis B and can usually be continued. During the medication period, patients should follow the doctor’s instructions to regularly monitor the changes of hepatitis B e antigen and surface antigen, and at the same time, they should avoid exertion and maintain sufficient sleep. Thymofaxin is a prescription drug, and patients with minor triple positive should follow the doctor’s instructions to use the drug, and should not blindly use it on their own, so as to avoid the adverse effects of the drug.